These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35912197)

  • 141. Occult stage IIIA-N2 patients have excellent overall survival with initial surgery.
    Kim MP; Correa AM; Hofstetter WL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Walsh GL; Erasmus JJ; Swisher SG
    J Thorac Dis; 2018 Dec; 10(12):6670-6676. PubMed ID: 30746212
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Relevance of Intraoperative Pleural Lavage Cytology and Histologic Subtype in Lung Adenocarcinoma.
    Mikubo M; Naito M; Matsui Y; Shiomi K; Ichinoe M; Yoshida T; Satoh Y
    Ann Thorac Surg; 2018 Dec; 106(6):1654-1660. PubMed ID: 30227125
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Predictors of recurrence and survival of pathological T1N0M0 invasive adenocarcinoma following lobectomy.
    Wang Y; Zheng D; Zheng J; Huang Q; Han B; Zhang J; Zhao H; Chen H
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1015-1023. PubMed ID: 29532227
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Indications for invasive mediastinal staging in patients with early non-small cell lung cancer staged with PET-CT.
    Gao SJ; Kim AW; Puchalski JT; Bramley K; Detterbeck FC; Boffa DJ; Decker RH
    Lung Cancer; 2017 Jul; 109():36-41. PubMed ID: 28577947
    [TBL] [Abstract][Full Text] [Related]  

  • 145. The Eighth Edition Lung Cancer Stage Classification.
    Detterbeck FC; Boffa DJ; Kim AW; Tanoue LT
    Chest; 2017 Jan; 151(1):193-203. PubMed ID: 27780786
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation.
    Suda K; Murakami I; Yu H; Ellison K; Shimoji M; Genova C; Rivard CJ; Mitsudomi T; Hirsch FR
    J Thorac Oncol; 2016 Oct; 11(10):1711-7. PubMed ID: 27257133
    [TBL] [Abstract][Full Text] [Related]  

  • 148. Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller.
    Hung JJ; Yeh YC; Jeng WJ; Wu YC; Chou TY; Hsu WH
    Eur J Cardiothorac Surg; 2016 Aug; 50(2):329-36. PubMed ID: 26819290
    [TBL] [Abstract][Full Text] [Related]  

  • 149. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
    Goldstraw P; Chansky K; Crowley J; Rami-Porta R; Asamura H; Eberhardt WE; Nicholson AG; Groome P; Mitchell A; Bolejack V; ;
    J Thorac Oncol; 2016 Jan; 11(1):39-51. PubMed ID: 26762738
    [TBL] [Abstract][Full Text] [Related]  

  • 150. Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart.
    Travis WD; Brambilla E; Burke AP; Marx A; Nicholson AG
    J Thorac Oncol; 2015 Sep; 10(9):1240-1242. PubMed ID: 26291007
    [No Abstract]   [Full Text] [Related]  

  • 151. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma.
    Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y
    Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Prognostic Impact of Intra-alveolar Tumor Spread in Pulmonary Adenocarcinoma.
    Warth A; Muley T; Kossakowski CA; Goeppert B; Schirmacher P; Dienemann H; Weichert W
    Am J Surg Pathol; 2015 Jun; 39(6):793-801. PubMed ID: 25723114
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Predictive risk factors for lymph node metastasis in patients with small size non-small cell lung cancer.
    Bao F; Yuan P; Yuan X; Lv X; Wang Z; Hu J
    J Thorac Dis; 2014 Dec; 6(12):1697-703. PubMed ID: 25589962
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts.
    Li S; Li L; Zhu Y; Huang C; Qin Y; Liu H; Ren-Heidenreich L; Shi B; Ren H; Chu X; Kang J; Wang W; Xu J; Tang K; Yang H; Zheng Y; He J; Yu G; Liang N
    Br J Cancer; 2014 May; 110(11):2812-20. PubMed ID: 24743704
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Feasibility of segmental resection in non-small-cell lung cancer with ground-glass opacity.
    Iwata H; Shirahashi K; Mizuno Y; Yamamoto H; Takemura H
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):375-9; discussion 379. PubMed ID: 24562008
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Fine-needle aspirates CYFRA 21-1 is a useful tumor marker for detecting axillary lymph node metastasis in breast cancer patients.
    Yoon JH; Han KH; Kim EK; Moon HJ; Kim MJ; Suh YJ; Choi JS; Park BW
    PLoS One; 2013; 8(2):e57248. PubMed ID: 23451192
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Predictive risk factors for mediastinal lymph node metastasis in clinical stage IA non-small-cell lung cancer patients.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    J Thorac Oncol; 2012 Aug; 7(8):1246-51. PubMed ID: 22659962
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.
    Scagliotti GV; Pastorino U; Vansteenkiste JF; Spaggiari L; Facciolo F; Orlowski TM; Maiorino L; Hetzel M; Leschinger M; Visseren-Grul C; Torri V
    J Clin Oncol; 2012 Jan; 30(2):172-8. PubMed ID: 22124104
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Survival benefit of neoadjuvant chemotherapy in non-small cell lung cancer: an updated meta-analysis of 13 randomized control trials.
    Song WA; Zhou NK; Wang W; Chu XY; Liang CY; Tian XD; Guo JT; Liu X; Liu Y; Dai WM
    J Thorac Oncol; 2010 Apr; 5(4):510-6. PubMed ID: 20107424
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Genomics Analysis and Nomogram Risk Prediction of Occult Lymph Node Metastasis in Non-Predominant Micropapillary Component of Lung Adenocarcinoma Measuring ≤ 3 cm.
    Wang K; Xue M; Qiu J; Liu L; Wang Y; Li R; Qu C; Yue W; Tian H
    Front Oncol; 2022; 12():945997. PubMed ID: 35912197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 8.